| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/24/2011 | WO2010124201A3 Compositions and methods for treatment of cardiovascular disease |
| 03/24/2011 | WO2010108001A3 Agents and methods for tissue repair and regeneration |
| 03/24/2011 | WO2010058227A3 NOVEL USES OF VEGFxxxB |
| 03/24/2011 | US20110071612 Anti-angiogenic compositions and methods of use |
| 03/24/2011 | US20110071499 Free-standing biodegradable patch |
| 03/24/2011 | US20110071498 Free-standing biodegradable patch |
| 03/24/2011 | US20110071225 Method for obtaining a sequoyitol-containing extract from genus nephrolepis and uses thereof |
| 03/24/2011 | US20110071217 Process for the Synthesis of 4,5,6,7-tetrachloro-3',6'-dihydroxy-2',4',5',7'-tetraiodo-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one (Rose Bengal) and Related Xanthenes |
| 03/24/2011 | US20110071211 MicroRNA (miRNA) And Downstream Targets For Diagnostic And Therapeutic Purposes |
| 03/24/2011 | US20110071204 Percutaneous absorption preparation |
| 03/24/2011 | US20110071198 Nicotinic acid receptor ligands |
| 03/24/2011 | US20110071197 Bis-aryl compounds for use as medicaments |
| 03/24/2011 | US20110071196 Compounds Which Selectively Modulate The CB2 Receptor |
| 03/24/2011 | US20110071179 Macrocyclic inhibitors of jak |
| 03/24/2011 | US20110071176 Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same |
| 03/24/2011 | US20110071164 Erg channel openers for the treatment of cardiac arrhythmias |
| 03/24/2011 | US20110071160 1,3-DIHYDRO-2H-PYRROLO[3,2-b]PYRIDIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF |
| 03/24/2011 | US20110071159 6- (4-cyclopropylpiperazin-1-yl) -2 ' -methyl- [3, 4 ' ] -bipyridine and its use as a medicament |
| 03/24/2011 | US20110071152 5-membered heterocycle-based p38 kinase inhibitors |
| 03/24/2011 | US20110071148 Compounds as the estrogen related receptors modulators and the uses thereof |
| 03/24/2011 | US20110071145 Raf Modulators And Methods Of Use |
| 03/24/2011 | US20110071144 Quinazoline derivatives and pharmaceutical compositions containing them |
| 03/24/2011 | US20110071139 Cycloalkyl Lactame Derivatives As Inhibitors Of 11-Beta-Hydroxysteroid Dehydrogenase 1 |
| 03/24/2011 | US20110071133 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 03/24/2011 | US20110071132 Substituted oxindole derivatives, drugs containing said derivatives and the use thereof |
| 03/24/2011 | US20110071131 Substituted Spirocyclic Piperidine Derivatives as Histamine-3 (H3) Receptor Ligands |
| 03/24/2011 | US20110071130 2-aminobenzimidazoles for treating neurodegenerative diseases |
| 03/24/2011 | US20110071115 Pharmaceutically useful heterocycle-substituted lactams |
| 03/24/2011 | US20110071113 Thiazole Derivatives and Use Thereof |
| 03/24/2011 | US20110071111 Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome |
| 03/24/2011 | US20110071107 Uses of water-soluble cellulose derivatives for preventing or treating metabolic syndrome |
| 03/24/2011 | US20110071095 Compositions and Methods for Increasing Telomerase Activity |
| 03/24/2011 | US20110071087 Polypeptides having modulatory effects on cells |
| 03/24/2011 | US20110071086 Compositions for tissue repair/regeneration |
| 03/24/2011 | US20110071084 Benzazepine derivatives useful as vasopressin antagonists |
| 03/24/2011 | US20110070309 Pharmaceutical formulation comprising a water-insoluble active agent |
| 03/24/2011 | US20110070307 Tissue regeneration |
| 03/24/2011 | US20110070291 Food or beverage composition fortified with thyronamines and/or thyronamine precursors |
| 03/24/2011 | US20110070282 Materials and Methods for Treating Skeletal System Damage and Promoting Skeletal System Repair and Regeneration |
| 03/24/2011 | US20110070281 Reparative cell delivery via hyaluronic acid vehicles |
| 03/24/2011 | US20110070272 Materials and Methods for Modulating Metabolism |
| 03/24/2011 | US20110070205 Multipotent stem cells and uses thereof |
| 03/24/2011 | US20110070184 Methods and compositions for treating atherosclerosis and related condidtions |
| 03/24/2011 | US20110070176 Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid |
| 03/24/2011 | CA2774460A1 Inhibition of endosomal toll-like receptor activation |
| 03/24/2011 | CA2774239A1 Treatment for oxidative stress and/or hypertension |
| 03/24/2011 | CA2773744A1 Methods of treating a patient receiving a cardiac stent implant |
| 03/24/2011 | CA2773125A1 Compounds having tafia inhibitory activity |
| 03/24/2011 | CA2772689A1 Glycine compound |
| 03/23/2011 | EP2298803A2 Human G-protein coupled receptor and ligands thereof |
| 03/23/2011 | EP2298757A2 Urea compounds active as vanilloid receptor antagonist for the treatment of pain |
| 03/23/2011 | EP2298747A1 Triazole derivative or salt thereof |
| 03/23/2011 | EP2298735A1 Aminocyclohexyl ether compounds and uses thereof |
| 03/23/2011 | EP2298355A2 Albumin fusion proteins |
| 03/23/2011 | EP2298348A1 Antibody binding alpha4Beta7 integrin and its use to treat inflammatory bowel disease |
| 03/23/2011 | EP2298334A2 Tweak receptor |
| 03/23/2011 | EP2298333A2 Tweak receptor |
| 03/23/2011 | EP2298332A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 03/23/2011 | EP2298308A2 Integrin-binding small molecules |
| 03/23/2011 | EP2298301A2 Medicaments for increasing endogenous Erythropoietin (EPO) |
| 03/23/2011 | EP2298300A1 Compositions for inhibition of anglogenesis comprising thalidomide and aspirin |
| 03/23/2011 | EP2298298A2 Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors |
| 03/23/2011 | EP2298297A1 Combination of an inhibitor of the If current of the sinus node and an inhibitor of the angiotensin converting enzyme |
| 03/23/2011 | EP2298292A2 Kinase inhibitors for treating cancers |
| 03/23/2011 | EP2298291A2 Kinase inhibitors for treating cancers |
| 03/23/2011 | EP2298284A2 Mucoadhesive pharmaceutical formulations |
| 03/23/2011 | EP2298283A2 Pharmaceutical formulations comprising cannabinoids |
| 03/23/2011 | EP2298278A1 Prevention and reduction of blood loss |
| 03/23/2011 | EP2297142A1 Novel substituted pyridin-2-ones and pyridazin-3-ones |
| 03/23/2011 | EP2297137A1 Novel heteroaryl carboxamide derivatives |
| 03/23/2011 | EP2297118A1 N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperaz ine derivatives |
| 03/23/2011 | EP2297117A1 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |
| 03/23/2011 | EP2297113A1 Dual-acting antihypertensive agents |
| 03/23/2011 | EP2297106A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states |
| 03/23/2011 | EP2297104A1 2-alkoxy-substituted dicyanopyridines and use thereof |
| 03/23/2011 | EP2296684A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
| 03/23/2011 | EP2296680A1 Labisia pumila extracts for reducing the risk of cardiovascular diseases |
| 03/23/2011 | EP2296666A1 Use of fts for the treatment of myocardial ischemia/reperfusion injury |
| 03/23/2011 | EP2296649A1 Oxazolidinones for the treatment of inflammatory conditions of the gastrointestinal tract |
| 03/23/2011 | EP2296646A2 Novel treatments |
| 03/23/2011 | EP2296642A1 Compositions comprising amino acids, with pro-angiogenic activity |
| 03/23/2011 | EP2296641A1 Diaryl urea for treating heart failure |
| 03/23/2011 | EP2205604B1 {[5-(phenyl)-6-phenylpyrrolo[2,1-f][2,1,4]triazin-4-yl]amino}carboxylic acid derivatives and related compounds as prostacyclin (pgi2) ip receptor activators for treating cardiovascular disorders |
| 03/23/2011 | EP1983990B1 A3 adenosine receptor allosteric modulators |
| 03/23/2011 | EP1896417B1 Linear urea mimics antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 03/23/2011 | EP1843764B1 Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic |
| 03/23/2011 | EP1469878B1 Fgfr agonists |
| 03/23/2011 | EP1330444B1 Nitrogenous heterocyclic compounds and process for making them |
| 03/23/2011 | EP1278748B1 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 03/23/2011 | CN201767299U Pillow for beauty |
| 03/23/2011 | CN1951372B Solid oral dosage forms comprising valsartan and HCTZ |
| 03/23/2011 | CN1931233B Medicine composition of red sage and epimedium for treating cardiac and cerebral vascular diseases |
| 03/23/2011 | CN1931217B Medicine composition of gingko leaf and rhodiola root |
| 03/23/2011 | CN1931216B Medicine composition of safflower and rhodiola root |
| 03/23/2011 | CN1923228B Pharmaceutical composition comprising notoginseng extract, Danshen extract and ligustrazine |
| 03/23/2011 | CN1919243B Traditional medicine composition for treating cardiovascular and cerebrovascular diseases |
| 03/23/2011 | CN1903241B Method for extraction and separation of pseudo-ginseng |
| 03/23/2011 | CN1872155B Microspheres in use for injection of astragalus root and red sage root, and preparation method |
| 03/23/2011 | CN1847236B 7,8-dihydroxy-2-oxo-2H-benzopyran derivative and its synthesis process and medicinal use |
| 03/23/2011 | CN1785283B Medicinal composition for treating cardiorascular disease and its preparation method |